3 results match your criteria Recent Patents on Biomedical Engineering [Journal]

  • Page 1 of 1

Design and Application of Magnetic-based Theranostic Nanoparticle Systems.

Recent Pat Biomed Eng 2013 Apr;6(1):47-57

Department of Bioengineering, The University of Texas at Arlington, Arlington, TX 76019 ; Joint Biomedical Engineering Program between The University of Texas at Arlington and The University of Texas Southwestern Medical Center, Dallas, TX 75390.

Recently, magnetic-based theranostic nanoparticle (MBTN) systems have been studied, researched, and applied extensively to detect and treat various diseases including cancer. Theranostic nanoparticles are advantageous in that the diagnosis and treatment of a disease can be performed in a single setting using combinational strategies of targeting, imaging, and/or therapy. Of these theranostic strategies, magnetic-based systems containing magnetic nanoparticles (MNPs) have gained popularity because of their unique ability to be used in magnetic resonance imaging, magnetic targeting, hyperthermia, and controlled drug release. Read More

View Article

Download full-text PDF

Source
http://www.bme.psu.edu/labs/Yang-lab/publications%20PDF/Anik
Web Search
http://www.eurekaselect.com/openurl/content.php?genre=articl
Publisher Site
http://dx.doi.org/10.2174/1874764711306010007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686518PMC
April 2013
14 Reads

Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.

Recent Pat Biomed Eng 2012 Apr;5(1):83-101

Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108-2718, USA.

Advancements in the field and rising interest among pharmaceutical researchers have led to the development of new molecules with enhanced therapeutic activity. Design of new drugs which can target a particular pathway and/or explore novel targets is of immense interest to ocular pharmacologists worldwide. Delivery of suitable pharmacologically active agents at proper dose (within the therapeutic window) to the target tissues without any toxicity to the healthy ocular tissues still remain an elusive task. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1874764711205010083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235159PMC
April 2012
17 Reads

Recent Patents and Advances in the Next-Generation Sequencing Technologies.

Recent Pat Biomed Eng 2008 ;2008(1):60-67

The Institute for Systems Biology, Seattle, WA, 98021 USA.

We are now witnessing a new genomic revolution due to the arrival and continued advancements in the next-generation high-throughput sequencing technologies, which encompass sequencing by synthesis including fluorescent in situ sequencing (FISSEQ) and pyrosequencing, sequencing by ligation including using polony amplification and supported oligonucleotide detection (SOLiD), sequencing by hybridization in combination with sequencing-by-ligation and nanopore technology, nanopore sequencing and other novel sequencing technologies using nano-transistor array, scanning tunneling microscopy and nanowire molecule sensors etc. We review here major technologies and recent patents for achieving high-throughput, ultra-fast, extremely cheap, and highly accurate sequencing. We will see enormous impacts of these next-generation sequencing methods for solving complex biological problems and for ushering in the practice of personalized medicine. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122325PMC
January 2008
30 Reads
  • Page 1 of 1